My interests

Receive our interest that have beensaved and send them to one of your contacts by entering a valid email address :

Sign up to our news and newsletters

Sign me up to these newsletters:

  • Capital Market

  • Civil Business Law

  • Civil Liability

  • Competition-Distribution Law

  • Employment Law

  • IARD (Fire, Accidents and Multi-Risk) Insurance

  • Insurance/Construction

  • Medical Liability

  • Public Law

Sign me up to these Brèves:

  • Brèves d'actualités

  • News flashes


Thank you, you are registered



  • Paris

  • Paris

Languages : French, English

Paris Bar (2008)
Partner at Racine since 2024

Contact :

Tel : +33 1 44 82 43 00

Add to my interests


Gide Loyrette Nouel (2014 – 2017)

Vivien & Associés (2008 – 2014)

CMS Bureau Francis Lefebvre


Doctorate in law (Social Sciences of Toulouse University)

Post graduate degree, business law

Graduate degree, business law



  • Legal 500 - 2022: Mergers & Acquisitions
  • Chambers - 2022: M&A
  • Legal 500 - 2021: EU Law, Competition and Distribution
  • Le Point - 2021: Mergers & Acquisitions – Corporate Law
  • Option Droit et Affaires - 2018: M&A
  • International Financial Law Review - 2018: M&A
  • Chambers - 2018: M&A (Mergers & Acquisitions)
  • Legal 500 - 2018: M&A


  • 2023: Sommet du Droit

    LBO, lower mid & small cap transactions

  • 2015: Trophées du droit et du contentieux

    Mergers & Acquisitions – small- and mid-cap: Silver trophy

    Entrepreneurial firm over five years old: Gold trophy

  • 2018: Top Legal

    Top Legal

  • 2018: Trophées du droit et du contentieux

    Mergers & Acquisitions : Small & Mid Cap: Gold trophy

The team

01 / 24
View all our teams

News and latest publications

Press releases


Racine advises the founders Iris Knobloch, Groupe Artemis and Combat Holding in the creation of the first European SPAC dedicated to the entertainment and leisure industry, I2PO

The full version of this article is in french. Click below to read it
Read more

Press releases


Racine advises AG2R La Mondiale on its acquisition of a stake in the capital of Nexity

The full version of this article is in French Click below to read it
Read more

Press releases


Racine advises Onward Therapeutics on its investment to Biomunex and EMERCell, two biotech start-ups

Racine advises Onward Therapeutics, a Swiss biotechnology company active in the field of oncology, on its acquisition of minority stakes in Biomunex and EMERCell. These transactions represent Onward Therapeutics’ first two strategic investments in France. Headed by the successful biotech...
Read more
View all

Receive our information